Rudy Li
Stock Analyst at Chardan Capital
(1.95)
# 3,010
Out of 4,876 analysts
17
Total ratings
47.06%
Success rate
-8.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRTA Prothena Corporation | Maintains: Buy | $40 → $18 | $6.08 | +196.05% | 5 | May 27, 2025 | |
| DRUG Bright Minds Biosciences | Maintains: Buy | $80 | $23.27 | +243.79% | 2 | May 21, 2025 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $55 | $32.40 | +69.75% | 2 | May 13, 2025 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $20 | $6.55 | +205.34% | 3 | May 9, 2025 | |
| CNTA Centessa Pharmaceuticals | Initiates: Buy | $30 | $13.20 | +127.27% | 1 | May 8, 2025 | |
| PRAX Praxis Precision Medicines | Initiates: Buy | $80 | $43.00 | +86.05% | 1 | May 7, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $24 | $11.63 | +106.45% | 3 | Mar 19, 2025 |
Prothena Corporation
May 27, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $6.08
Upside: +196.05%
Bright Minds Biosciences
May 21, 2025
Maintains: Buy
Price Target: $80
Current: $23.27
Upside: +243.79%
Xenon Pharmaceuticals
May 13, 2025
Maintains: Buy
Price Target: $55
Current: $32.40
Upside: +69.75%
Mind Medicine (MindMed)
May 9, 2025
Maintains: Buy
Price Target: $20
Current: $6.55
Upside: +205.34%
Centessa Pharmaceuticals
May 8, 2025
Initiates: Buy
Price Target: $30
Current: $13.20
Upside: +127.27%
Praxis Precision Medicines
May 7, 2025
Initiates: Buy
Price Target: $80
Current: $43.00
Upside: +86.05%
Stoke Therapeutics
Mar 19, 2025
Maintains: Buy
Price Target: $24
Current: $11.63
Upside: +106.45%